{"title":"THE INFLUENCE OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY ON QUALITY OF LIFE IN INDIVIDUALS WITH MULTIPLE MYELOMA","authors":"Abhishekh Pratap Singh, Anoop Mantri, Pooja Gandhi","doi":"10.36106/gjra/3505631","DOIUrl":null,"url":null,"abstract":"Objective: This study aimed to evaluate the symptoms of chemotherapy-induced peripheral neuropathy\n(CIPN) and its impact on health-related quality of life (HRQOL) in multiple myeloma (MM) patients.\nMethods: A cross-sectional survey was conducted among MM patients at a tertiary care hospital, utilizing the European\nOrganization for Research and Treatment of Cancer Quality-of-Life Questionnaire for CIPN scale (QLQ-CIPN20) and the\nEORTC multiple myeloma module (QLQ-MY20). Descriptive statistics were used for data presentation. Results: 26 patients\nparticipated, with 61.5% being male. The average age was 64.34 ± 8.49 years. CIPN symptoms included tingling, numbness,\nand difculty in walking. HRQOL challenges encompassed bone pain, back pain, feeling ill, hair loss, and concerns about\nhealth and mortality. Conclusion: MM patients experience CIPN symptoms, impacting their HRQOL. Incorporating CIPN\nassessments as patient-reported outcomes is crucial in routine clinical practice.","PeriodicalId":12664,"journal":{"name":"Global journal for research analysis","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal for research analysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36106/gjra/3505631","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study aimed to evaluate the symptoms of chemotherapy-induced peripheral neuropathy
(CIPN) and its impact on health-related quality of life (HRQOL) in multiple myeloma (MM) patients.
Methods: A cross-sectional survey was conducted among MM patients at a tertiary care hospital, utilizing the European
Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire for CIPN scale (QLQ-CIPN20) and the
EORTC multiple myeloma module (QLQ-MY20). Descriptive statistics were used for data presentation. Results: 26 patients
participated, with 61.5% being male. The average age was 64.34 ± 8.49 years. CIPN symptoms included tingling, numbness,
and difculty in walking. HRQOL challenges encompassed bone pain, back pain, feeling ill, hair loss, and concerns about
health and mortality. Conclusion: MM patients experience CIPN symptoms, impacting their HRQOL. Incorporating CIPN
assessments as patient-reported outcomes is crucial in routine clinical practice.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
